| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | A9C8MNF7CA |
| InChI Key | MQIMZDXIAHJKQP-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H10FNO3 |
| Molecular Weight | 271.25 |
| AlogP | 3.69 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 66.49 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 20.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group A
Nuclear hormone receptor subfamily 3 group A member 1
|
- | 1216 | - | - | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group A
Nuclear hormone receptor subfamily 3 group A member 2
|
- | 5-5 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Endometriosis | 2 | D004715 | ClinicalTrials |
| Crohn Disease | 1 | D003424 | ClinicalTrials |
| Long QT Syndrome | 1 | D008133 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL450940 |
| DrugBank | DB06832 |
| FDA SRS | A9C8MNF7CA |
| Guide to Pharmacology | 6700 |
| PDB | 041 |
| PubChem | 656954 |
| SureChEMBL | SCHEMBL1379424 |
| ZINC | ZINC000003817763 |